Classification of systemic therapies for potential stabilization of the vulnerable plaque to prevent acute myocardial infarction

被引：23

作者：

Ambrose, JA ^{[1
]}

D'Agate, DJ ^{[1
]}

机构：

[1] New York Med Coll, Comprehens Cardiovasc Ctr, St Vincent Catholic Med Ctr New York, New York, NY USA

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2005年 / 95卷 / 03期

关键词：

D O I：

10.1016/j.amjcard.2004.09.037

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In this editorial, a classification of systemic therapies for potential plaque stabilization of vulnerable plaque to prevent acute myocardial infarction is proposed based on both biologic plausibility (a potential mechanism to explain the effect) and clinical evidence (i.e., whether the agent reduced acute myocardial infarction in well-designed clinical trials). All therapies possess biologic plausibility but are classified into groups I to IV based on clinical data. (C)2005 by Excerpta Medica Inc.

引用

收藏

页码：379 / 382

页数：4

相关论文

共 48 条

[1] EFFECTS OF CAPTOPRIL ON ATHEROSCLEROSIS IN CYNOMOLGUS MONKEYS [J].

ABERG, G ;

FERRER, P .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1990, 15 :S65-S72

[2]

*ALLHAT OFF COORD, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981

[3] LIPID DEPLETION IN ATHEROMATOUS CORONARY-ARTERIES IN RHESUS-MONKEYS AFTER REGRESSION DIETS [J].

ARMSTRONG, ML ;

MEGAN, MB .

CIRCULATION RESEARCH, 1972, 30 (06) :675-+

[4] Vascular inflammation and the renin-angiotensin system [J].

Brasier, AR ;

Recinos, A ;

Eledrisi, MS .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (08) :1257-1266

[5] Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol [J].

Brousseau, ME ;

Schaefer, EJ ;

Wolfe, ML ;

Bloedon, LT ;

Digenio, AG ;

Clark, RW ;

Mancuso, JP ;

Rader, DJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) :1505-1515

[6] LIPID-LOWERING AND PLAQUE REGRESSION - NEW INSIGHTS INTO PREVENTION OF PLAQUE DISRUPTION AND CLINICAL EVENTS IN CORONARY-DISEASE [J].

BROWN, BG ;

ZHAO, XQ ;

SACCO, DE ;

ALBERS, JJ .

CIRCULATION, 1993, 87 (06) :1781-1791

[7] N-3 polyunsaturated fatty acids in coronary heart disease: A meta-analysis of randomized controlled trials [J].

Bucher, HC ;

Hengstler, P ;

Schindler, C ;

Meier, G .

AMERICAN JOURNAL OF MEDICINE, 2002, 112 (04) :298-304

[8] Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia effects of statin therapy [J].

Cipollone, F ;

Mezzetti, A ;

Porreca, E ;

Di Febbo, C ;

Nutini, M ;

Fazia, M ;

Falco, A ;

Cuccurullo, F ;

Davì, G .

CIRCULATION, 2002, 106 (04) :399-402

[9] Clinical trials update: highlights of the scientific sessions of the American College of Cardiology 2002: LIFE, DANAMI 2, MADIT-2, MIRACLE-ICD, OVERTURE, OCTAVE, ENABLE 1 & 2, CHRISTMAS, AFFIRM, RACE, WIZARD, AZACS, REMATCH, BNP trial and HARDBALL [J].

Coletta, A ;

Thackray, S ;

Nikitin, N ;

Cleland, JGF .

EUROPEAN JOURNAL OF HEART FAILURE, 2002, 4 (03) :381-388

[10] BLOOD-PRESSURE, STROKE, AND CORONARY HEART-DISEASE .2. SHORT-TERM REDUCTIONS IN BLOOD-PRESSURE - OVERVIEW OF RANDOMIZED DRUG TRIALS IN THEIR EPIDEMIOLOGIC CONTEXT [J].

COLLINS, R ;

PETO, R ;

MACMAHON, S ;

HEBERT, P ;

FIEBACH, NH ;

EBERLEIN, KA ;

GODWIN, J ;

QIZILBASH, N ;

TAYLOR, JO ;

HENNEKENS, CH .

LANCET, 1990, 335 (8693) :827-838

← 1 2 3 4 5 →